Linked Life Data

6146763

Source:http://linkedlifedata.com/resource/pubmed/id/6146763

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8396
pubmed:dateCreated
1984-8-30
pubmed:abstractText
A review of the progress of 176 patients with Parkinson's disease who were given maximum tolerated doses of L-dopa between November, 1969, and December, 1972, showed that the ratio of observed to expected deaths after 12 years' sustained therapy was 2.59 (2.14 for males and 3.64 for females). This contrasts with the overall 6-year follow-up figure for the same patients of 1.45 (1.29 for males and 1.85 for females). These findings indicate that although L-dopa may improve life expectancy during the first 6 years of therapy the protective effect subsequently declines.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0140-6736
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
211-2
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Effect of L-dopa on course of Parkinson's disease.
pubmed:publicationType
Journal Article